Cases & Deals

ArunA Biomedical issues $5.3 million of Common Stock in Reg D offering

Clients ArunA Biomedical, Inc.

Jones Day advised ArunA Biomedical, Inc., a manufacturer of technologies in human stem cell research for use in drug discovery and development, in connection with its issuance of $5.3 million of Common Stock in a Regulation D offering.